Skip Navigation

European Heart Journal 1992 13(Supplement D):56-61; doi:10.1093/eurheartj/13.suppl_D.56
Copyright © 1992 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rupp, H.
Right arrow Articles by Jacob, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rupp, H.
Right arrow Articles by Jacob, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 The European Society of Cardiology

Metabolically-modulated growth and phenotype of the rat heart

H. Rupp and R. Jacob

Institute of Physiology II, University of Tübingen Tübingen, Germany

Address for correspondence: Dr H. Rupp, Institute of Physiology II, Gmelinstrasse 5, 7400 Tübingen, Germany

Heart muscle reacts to work overload and various neuroendocrine stimuli by inducing myocyte growth. A novel type of hypertrophy can be induced in the rat heart by etomoxir, which reduces fatty acid oxidation. This hypoglycaemic drug inhibits the mitochondrial carnitine palmitoyltransferase 1, and thus reduces the long-chain fatty acid uptake of mitochondria; in a compensatory manner, the glycolytic flux is enhanced. In rats, etomoxir induced a harmonious growth of the left and right ventricles of normal and pressure-overloaded hearts. To characterize the protein phenotype, myosin expression and sarcoplasmic reticulum (SR) Ca2+ pump activity were determined. In contrast to pressure-overloaded hearts, etomoxir increased the proportion of myosin V1, Ca2+-stimulated SR ATPase activity and the rate of SR Ca2+ uptake. Since etomoxir did not increase blood pressure, heart rate or circulating thyroid hormones, it appears that established mechanisms of other models of cardiac hypertrophy were not involved. The etomoxir-induced changes thus seem closely linked to the shift in energy metabolism.

Key Words: Hypertrophy • metabolism • etomoxir • carnitine palmitoyltransferase • pressure overload


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
A. E. M. Vickers
Characterization of Hepatic Mitochondrial Injury Induced by Fatty Acid Oxidation Inhibitors
Toxicol Pathol, January 1, 2009; 37(1): 78 - 88.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Taegtmeyer
Cardiac Metabolism as a Target for the Treatment of Heart Failure
Circulation, August 24, 2004; 110(8): 894 - 896.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Y. Saburi, K. Okumura, H. Matsui, K. Hayashi, H. Kamiya, R. Takahashi, K. Matsubara, and M. Ito
Changes in distinct species of 1,2-diacylglycerol in cardiac hypertrophy due to energy metabolic disorder
Cardiovasc Res, January 1, 2003; 57(1): 92 - 100.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
L. de las Fuentes, P. Herrero, L. R. Peterson, D. P. Kelly, R. J. Gropler, and V. G. Davila-Roman
Myocardial Fatty Acid Metabolism: Independent Predictor of Left Ventricular Mass in Hypertensive Heart Disease
Hypertension, January 1, 2003; 41(1): 83 - 87.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
G. J van der Vusse, M. van Bilsen, and J. F.C Glatz
Cardiac fatty acid uptake and transport in health and disease
Cardiovasc Res, January 14, 2000; 45(2): 279 - 293.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.